Nutrient Induced Type 2 and Chemical Induced Type 1 Experimental Diabetes Differently Modulate Gastric GLP-1 Receptor Expression

Nutrient Induced Type 2 and Chemical Induced Type 1 Experimental Diabetes Differently Modulate Gastric GLP-1 Receptor Expression

T2DM patients demonstrate reduced GLP-1 receptor (GLP-1R) expression in their gastric glands. Whether induced T2DM and T1DM differently affect the gastric GLP-1R expression is not known. This study assessed extrapancreatic GLP-1R system in glandular stomach of rodents with different types of experim...

Full description

Bibliographic Details
Main Authors:	Olga Bloch, Efrat Broide, Gilad Ben-Yehudah, Dror Cantrell, Haim Shirin, Micha J. Rapoport
Format:	Article
Language:	English
Published:	Hindawi Limited 2015-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2015/561353

Similar Items

Simultaneous analyses of carbohydrate-mediated serum GLP-1 and GLP-2 and duodenal receptor expression in children with and without celiac disease
by: Marianna Rachmiel, et al.
Published: (2019-04-01)

Purslane Effect on GLP-1 and GLP-1 receptor in type 2 diabetes
by: Sara Heidarzadeh, et al.
Published: (2013-01-01)

Purslane Effect on GLP-1 and GLP-1 receptor in type 2 diabetes
by: Roja Daliri, et al.
Published: (2013-01-01)

The anorectic effect of GLP-1 in rats is nutrient dependent.
by: Darleen Sandoval, et al.
Published: (2012-01-01)

Polymorphisms of GLP-1 Receptor Gene and Response to GLP-1 Analogue in Patients with Poorly Controlled Type 2 Diabetes
by: Chia-Hung Lin, et al.
Published: (2015-01-01)

GLP-1 reduces metalloproteinase-9 induced by both hyperglycemia and hypoglycemia in type 1 diabetes. The possible role of oxidative stress
by: Ceriello A, et al.
Published: (2015-06-01)

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
by: Mette Simone Aae Madsen, et al.
Published: (2019-10-01)

The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain
by: Choon Sang Bae, et al.
Published: (2017-11-01)

Emerging technologies to achieve oral delivery of GLP-1 and GLP-1 analogs for treatment of type 2 diabetes mellitus (T2DM)
by: Shengwu Ma, et al.
Published: (2017-04-01)

Effect of Modified Roux-en-Y Gastric Bypass Surgery on GLP-1, GIP in Patients with Type 2 Diabetes Mellitus
by: Shao-Wei Xiong, et al.
Published: (2015-01-01)

Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice
by: Yanming Wang, et al.
Published: (2020-05-01)

Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice
by: Efrat Broide, et al.
Published: (2020-02-01)

Review: The evolving world of GLP-1 agonist therapies for type 2 diabetes
by: Kevin C. R. Baynes
Published: (2010-06-01)

GLP-1 Receptor Agonists and Cardiovascular Disease in Patients with Type 2 Diabetes
by: María Isabel del Olmo-Garcia, et al.
Published: (2018-01-01)

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art
by: Michael A. Nauck, et al.
Published: (2021-04-01)

Glucagon receptor antagonist upregulates circulating GLP-1 level by promoting intestinal L-cell proliferation and GLP-1 production in type 2 diabetes
by: Shan Lang, et al.
Published: (2020-04-01)

Serum Levels of Incretin Hormones – GLP-1 and GIP in Patients with Type 1 Diabetes Mellitus
by: Stanchev Pavel E., et al.
Published: (2019-03-01)

Allosteric modulation of the activity of the glucagon-like peptide-1 (GLP-1) metabolite GLP-1 9-36 amide at the GLP-1 receptor.
by: Naichang Li, et al.
Published: (2012-01-01)

GLP-1/GLP-1R Signaling in Regulation of Adipocyte Differentiation and Lipogenesis
by: Jicui Chen, et al.
Published: (2017-06-01)

The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats
by: Lin-Yu Wang, et al.
Published: (2017-10-01)

Selecting probiotics with the abilities of enhancing GLP-1 to mitigate the progression of type 1 diabetes in vitro and in vivo
by: Shih-Hung Wei, et al.
Published: (2015-10-01)

Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
by: Kristina S. Boye, et al.
Published: (2019-05-01)

The role and therapeutic potential of GLP-1 analogues as a treatment for type 2 diabetes
by: Lavery, Kerry Susan
Published: (2006)

Regulation of pancreatic and gastric endocrine secretion by GIP and GLP-1(7-36) amide
by: Jia, Xiaoyan
Published: (2009)

Regulation of pancreatic and gastric endocrine secretion by GIP and GLP-1(7-36) amide
by: Jia, Xiaoyan
Published: (2009)

Expression of Duodenal Iron Transporter Proteins in Diabetic Patients with and without Iron Deficiency Anemia
by: Efrat Broide, et al.
Published: (2018-01-01)

Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis
by: Li Yang, et al.
Published: (2021-01-01)

Protective Effects of GLP-1 Analogue (Liraglutide) Against Amyloid β-induced Neurotoxicity
by: Shan-KO Tsai, et al.
Published: (2016)

GLP-1 Inhibits High-Glucose-Induced Oxidative Injury of Vascular Endothelial Cells
by: Quan Li, et al.
Published: (2017-08-01)

Regulation of microbiotaGLP1 axis by sennoside A in diet-induced obese mice
by: Jiamei Le, et al.
Published: (2019-07-01)

GLP-1 receptor agonists can reverse immunosuppression-induced beta-cell dysfunction
by: S. Bertera, et al.
Published: (2020-10-01)

Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming
by: Adrian Villalba, et al.
Published: (2020-05-01)

Efficacy and tolerability of GLP-1 agonists in patients with type 2 diabetes mellitus: an Indian perspective
by: Mala Dharmalingam
Published: (2014-12-01)

Relationship between diet/exercise and pharmacotherapy to enhance the GLP‐1 levels in type 2 diabetes
by: Yuki Fujiwara, et al.
Published: (2019-07-01)

The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date
by: Antza C, et al.
Published: (2019-08-01)

Preparation of the recombinant GLP-1
by: WU YAN RU, et al.
Published: (2017)

Glucolipotoxicity and GLP-1 secretion
by: Jung-Hee Hong, et al.
Published: (2021-08-01)

Glucagon, GLP-1 and Thermogenesis
by: Ismael González-García, et al.
Published: (2019-07-01)

GLP-1 and Intestinal Diseases
by: Jenna Elizabeth Hunt, et al.
Published: (2021-04-01)

Novel GLP-1 fusion chimera as potent long acting GLP-1 receptor agonist.
by: Qinghua Wang, et al.
Published: (2010-09-01)